Denali Therapeutics (DNLI) - Shares outstanding

Number of shares outstanding as of July 2026 : 186,636,978

According to Denali Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 186,636,978. At the end of 2026 the company had 186,636,978 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Denali Therapeutics from 2017 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	0.18 B	6.37%
2025	0.17 B	3.16%
2024	0.17 B	23.03%
2023	0.13 B	4.04%
2022	0.13 B	8.77%
2021	0.12 B	1.67%
2020	0.12 B	25.07%
2019	96.07 M	1.89%
2018	94.29 M	206.72%
2017	30.74 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Organovo ONVO	1,504,713	-99.19%	🇺🇸 USA
Orchard Therapeutics ORTX	22,838,856	-87.76%	🇬🇧 UK
Novavax NVAX	163,276,000	-12.52%	🇺🇸 USA
Novocure NVCR	114,149,838	-38.84%	Jersey

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Denali Therapeutics (DNLI)

Number of shares outstanding as of July 2026 : 186,636,978